Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2012
05/24/2012CA2817093A1 Nampt inhibitors
05/24/2012CA2816594A1 Nampt and rock inhibitors
05/23/2012EP2455383A2 4 -substituted azaadamantane derivatives and methods of use thereof
05/23/2012EP2455382A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
05/23/2012EP2455381A1 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor and erythropoietin production inducer
05/23/2012EP2455380A1 Heterocyclic compound and use thereof
05/23/2012EP2455379A1 Crystals of pyrroloquinolinequinone sodium salts
05/23/2012EP2455378A1 Carbazole and carboline derivatives, and preparation and therapeutic applications thereof
05/23/2012EP2454257A1 Pyrrolopyridine inhibitors of kinases
05/23/2012EP2454256A1 Process for the synthesis of paliperidone
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/23/2012EP2454250A1 Apoptosis signal-regulating kinase inhibitors
05/23/2012EP2454239A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
05/23/2012EP2454216A1 Non-polar and polar leaving groups
05/23/2012CN202223927U Vacuum sublimation and extraction device
05/23/2012CN1906162B Hydroxy piperidine derivatives to treat gaucher disease
05/23/2012CN102471340A 咪唑并吡啶衍生物及包含它的有机电致发光元件 Imidazopyridine derivatives and it contains the organic electroluminescence element
05/23/2012CN102471339A 激酶的吡咯并吡啶抑制剂 Kinase inhibitors pyrrolopyridine
05/23/2012CN102471338A 新的氮杂杂环化合物 The new aza-heterocyclic compounds
05/23/2012CN102471337A Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent
05/23/2012CN102471336A 吡咯并喹啉醌的钠盐结晶 Pyrrolo-quinoline quinone and the crystalline sodium salt of
05/23/2012CN102471335A Azabicyclo compound and salt thereof
05/23/2012CN102471334A 促代谢型谷氨酸受体调节剂 Metabotropic glutamate receptor modulators
05/23/2012CN102471317A 用于治疗肿瘤和炎性疾病的氨基吡啶衍生物 For the treatment of cancer and inflammatory diseases aminopyridine derivative
05/23/2012CN102471293A Oxazine derivatives and their use as BACE inhibitors for the treatment of neurological disorders
05/23/2012CN102471269A 含氮杂环衍生物及含有它的有机电致发光元件 Nitrogen-containing heterocyclic derivative and its organic electroluminescence element
05/23/2012CN102471260A Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
05/23/2012CN102471176A 非极性和极性离去基团 Nonpolar and polar leaving group
05/23/2012CN102464615A 芳基异喹啉类衍生物及其药物组合物、制备方法和用途 Aryl isoquinoline derivatives and pharmaceutical compositions thereof, preparation and use
05/23/2012CN101941969B Preparation method of moxifloxacin hydrochloride
05/23/2012CN101880279B One-step synthetic method of symmetrical 1,10-phenanthroline derivatives
05/23/2012CN101768369B Weather-resistance perylene imide dye and preparation method and application thereof
05/23/2012CN101641353B Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
05/23/2012CN101562232B Color-adjustable organic electroluminescent device and preparation method thereof
05/23/2012CN101531683B Bipyridine ruthenium/osmium ECL marker with phenothiazine power supplying groups in molecules
05/23/2012CN101490051B Pyrido [2, 3-b] pyrazine derivatives useful as herbicidal compounds
05/23/2012CN101270118B Technique for spherosinin purification with continuous column chromatography
05/23/2012CN101012141B Method of manufacturing chiral sulfoxide compounds
05/22/2012US8183377 Process for the preparation of imidazopyridines
05/22/2012US8183375 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
05/22/2012US8183275 Substituted imidazoles as bombesin receptor subtype-3 modulators
05/22/2012US8183249 Inhibitors of AKT/PKB with anti-tumor activity
05/22/2012US8183238 Bicyclic and tricyclic compounds as KAT II inhibitors
05/18/2012WO2012064973A2 Heterocyclic compounds and uses thereof
05/18/2012WO2012064910A1 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/18/2012WO2012064815A1 Substituted azaindazole compounds
05/18/2012WO2012064706A1 Mutant-selective egfr inhibitors and uses thereof
05/18/2012WO2012062844A1 Novel microbiocides
05/18/2012WO2012062759A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
05/18/2012WO2012062752A1 RADIOLABELLED mGLuR2 PET LIGANDS
05/18/2012WO2012062751A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
05/18/2012WO2012062750A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
05/18/2012WO2012062687A1 Triazole derivatives and their use for neurological disorders
05/18/2012WO2012062462A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012WO2012062319A1 Radiolabelled phenylimidazole-based ligands
05/18/2012WO2012061926A1 Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
05/18/2012WO2012030106A3 Production method of intermediate compound for synthesizing medicament
05/18/2012WO2012024397A3 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
05/18/2012WO2012003418A3 Functionally selective ligands of dopamine d2 receptors
05/18/2012WO2011158108A3 Aryl substituted indoles and their use as blockers of sodium channels
05/18/2012CA2817577A1 Heterocyclic compounds and uses thereof
05/18/2012CA2817385A1 Radiolabelled phenylimidazole-based ligands
05/18/2012CA2817100A1 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/18/2012CA2816974A1 Piperidinone carboxamide indane cgrp receptor antagonists
05/18/2012CA2816769A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
05/18/2012CA2815742A1 Novel microbiocides
05/18/2012CA2815120A1 Radiolabelled mglur2 pet ligands
05/18/2012CA2815002A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/18/2012CA2814998A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/18/2012CA2814996A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
05/18/2012CA2812667A1 Triazole derivatives and their use for neurological disorders
05/17/2012US20120123124 Manufacturing process for Tadalafil from racemic or L-tryptophan
05/17/2012US20120122915 Crystalline forms of palonosetron hydrochloride
05/17/2012US20120122914 Sustained-release composition containing tetrahydropyrido[4,3-b]indole derivatives and preparation of the derivatives
05/17/2012US20120122911 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122900 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122899 Piperidinone carboxamide azaindane cgrp receptor antagonists
05/17/2012US20120122895 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/17/2012US20120122892 Chemical compounds
05/17/2012US20120122891 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
05/17/2012US20120122882 Substituted Pyrrolo-Pyrimidine Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors
05/17/2012US20120122876 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
05/17/2012US20120122860 Solid forms of sulfonamides and amino acids
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122853 Annelated n-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
05/17/2012US20120122847 Aurora kinase modulators and method of use
05/17/2012US20120122838 Heterocyclic compounds and uses thereof
05/17/2012US20120122837 Inhibitors of fatty acid binding protein
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122817 Heterocyclic urea derivatives and methods of use thereof
05/17/2012US20120122804 Substituted quinobenzoxazine analogs
05/17/2012US20120122784 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120122680 Mesoionic pesticides
05/17/2012US20120122679 Mesoionic pesticides
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121651 Pyrazolopyridines and analogs thereof
05/17/2012US20120121540 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
05/17/2012US20120121508 Radiolabeled cgrp antagonists
05/16/2012EP2453496A1 Organic electroluminescent element, novel compound, lighting device and display device
1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 646